Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
About us Practical matters How to find us T. Xu

Publications

Pretreatment risk model for radiation-induced lymphopenia is associated with adjuvant durvalumab efficacy in patients with unresectable stage III NSCLC